Patent details

Basic Information

Publication number:

EP2505662

PCT Application Number:

PCT/JP/2010/068909

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP108330150

PCT Publication Number:

WO/2011/065168

First applicant's nationality:

Translation Language:

EPO Publication Language:

Not available

English Title of Invention:

METHOD AND APPARATUS FOR PREDICTION OF PHARMACOLOGICAL EFFICACY OF HUMANIZED ANTI-TNF-alpha ANTIBODY DRUG ON RHEUMATOID ARTHRITIS

French Title of Invention:

PROCÉDÉ ET APPAREIL DE PRÉDICTION DE L'EFFICACITÉ PHARMACOLOGIQUE D'UN MÉDICAMENT À BASE D'ANTICORPS ANTI-TNF-alpha HUMANISÉ SUR LA POLYARTHRITE RHUMATOÏDE

German Title of Invention:

VERFAHREN UND VORRICHTUNG ZUR VORHERSAGE DER PHARMAKOLOGISCHEN WIRKSAMKEIT EINES WIRKSTOFFS AUF EINEM ANTI-TNF-alpha-ANTIKÖRPER ZUR BEHANDLUNG VON RHEUMATOIDER ARTHRITIS

SPC Number:

Dates

Filing date:

26/10/2010

Grant date:

27/01/2016

EP Publication Date:

27/01/2016

PCT Publication Date:

03/06/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/10/2012

EP B1 Publication Date:

27/01/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/10/2016

Expiration date:

26/10/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/10/2010

 

 

Name:

KayteeBio Co. & Ltd.

Address:

VenturePlaza Funabashi No.110, 1-17-25, Kita-Honcho Funaba, Chiba 273-0864, Japan (JP)

Inventor

Name:

TSUZAKA Kensei

Address:

Japan (JP)

Priority

Priority Number:

2009266539

Priority Date:

24/11/2009

Priority Country:

Japan (JP)

Classification

Main IPC Class:

C12Q 1/68;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages